<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2413-4341</journal-id>
<journal-title><![CDATA[Revista Paraguaya de Reumatología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. parag. reumatol.]]></abbrev-journal-title>
<issn>2413-4341</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Paraguaya de Reumatología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2413-43412022000100041</article-id>
<article-id pub-id-type="doi">10.18004/rpr/2022.08.01.41</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Frecuencias de eventos adversos posteriores a la vacunación para COVID-19 en pacientes con Lupus Eritematoso Sistémico de un centro de referencia en Asunción-Paraguay]]></article-title>
<article-title xml:lang="en"><![CDATA[Frequencies of adverse events following COVID-19 vaccination in patients with Systemic Lupus Erythematosus Erythematosus in a referral center in Asuncion-Paraguay]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[Cynthia Gisela Holt]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Weiler]]></surname>
<given-names><![CDATA[Maria Inés Albertini]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[Anahí Soledad Romero]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fleitas]]></surname>
<given-names><![CDATA[Claudia Belén Vallejos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bareiro]]></surname>
<given-names><![CDATA[Liz Marite Cañiza]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vergara]]></surname>
<given-names><![CDATA[Jazmin Elizabeth Wazwaz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ocampo]]></surname>
<given-names><![CDATA[Mauricio Javier Guerrero]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cano]]></surname>
<given-names><![CDATA[Juan José Ahrens]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[Eric Hernán Benegas]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bordón]]></surname>
<given-names><![CDATA[Guillermo Nicolas Aguirre]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[Anthon Daniel Torres]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[Patricia Lorena Martinez]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nicora]]></surname>
<given-names><![CDATA[Astrid Paats]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acosta-Colman]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Asunción Facultad de Ciencias Médicas Hospital de Clínicas, Departamento de Reumatología]]></institution>
<addr-line><![CDATA[San Lorenzo ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<volume>8</volume>
<numero>1</numero>
<fpage>41</fpage>
<lpage>44</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2413-43412022000100041&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2413-43412022000100041&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2413-43412022000100041&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: El objetivo de este estudio es determinar la frecuencia de eventos adversos de la vacunación contra el COVID-19 en pacientes con LES que son atendidos en centros médicos de referencia en Paraguay. Este es un estudio observacional, transversal, descriptivo. Se incluyeron 52 pacientes con LES que recibieron al menos una dosis de la vacuna anticovid. De los cuales el 100% recibieron la primera dosis, el 92,3% la segunda dosis y el 15,38% la tercera dosis; el 44,6% recibió Sputnik-V; 16% Moderna; 12,5% Pfizer, 7,1% AstraZeneca, 3,6% Covaxin y 2,1% Hayat Vax, 8 pacientes recibieron su tercera dosis correspondiente a 3 de Pfizer, 3 de Moderna, 2 de AstraZeneca. En las 108 dosis aplicadas se registraron un total de 43 evento advserso, el 95,3% dentro de los primeros 5 días y el resto a los 5 días. El 51,2% presentó el evento advserso tras la primera dosis, el 39,5% tras la segunda dosis y el 9,3% tras la tercera dosis. La duración media de los síntomas fue de 2,3 días ±1,4. El efecto adverso más importante fue el dolor en el sitio de inyección, seguido de fiebre y fatiga. La exacerbación del LES también se registró como evento advserso en el 8,3%. Se registraron efectos adversos leves, se concluye que vacunación contra COVID-19 es segura para pacientes con LES.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: The aim of this study is to determine the frequency of adverse events of COVID-19 vaccination in patients with SLE who are attended at referral medical centers in Paraguay. This is an observational, cross-sectional, descriptive study. Fifty-two patients with SLE who received at least one dose of anticovid vaccine were included. Of which 100% received the first dose, 92.3% the second dose and 15.38% the third dose; 44.6% received SputnikV; 16% Moderna; 12.5% Pfizer, 7.1% AstraZeneca, 3.6% Covaxin and 2.1% Hayat Vax, 8 patients received their third dose corresponding to 3 from Pfizer, 3 from Moderna, 2 from AstraZeneca. In the 108 doses applied, a total of 43 adverse events were recorded, 95.3% within the first 5 days and the rest at 5 days. A total of 51.2% presented the adverse event after the first dose, 39.5% after the second dose and 9.3% after the third dose. The mean duration of symptoms was 2.3 days ±1.4. The most important adverse effect was pain at the injection site, followed by fever and fatigue. Exacerbation of SLE was also recorded as an adverse event in 8.3%. Mild adverse effects were recorded, it is concluded that vaccination against covid 19 is safe for patients with SLE.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[eventos adversos]]></kwd>
<kwd lng="es"><![CDATA[vacuna]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[Lupus]]></kwd>
<kwd lng="en"><![CDATA[adverse events]]></kwd>
<kwd lng="en"><![CDATA[vaccine]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[Lupus]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>UNIMID</collab>
<source><![CDATA[Qué son las IMID]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="">
<collab>Ministerio de Salud Pública y Bienestar Social</collab>
<source><![CDATA[Programa Ampliado de Inmunizaciones PAI. Paraguay - Vacuna]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="">
<collab>CDC</collab>
<source><![CDATA[Posibles efectos secundarios después de vacunarse contra el COVID-19]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="">
<collab>Ser.es</collab>
<source><![CDATA[Reumatólogos aconsejan vacunarse frente a la COVID-19 con cualquier vacuna disponible]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Salud Familiar y Comunitaria Inmunización Integral de la Familia]]></source>
<year>2021</year>
<publisher-name><![CDATA[Paho.org]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cartas]]></surname>
<given-names><![CDATA[US]]></given-names>
</name>
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[VLA]]></given-names>
</name>
<name>
<surname><![CDATA[Obregón]]></surname>
<given-names><![CDATA[MDÁ]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez]]></surname>
<given-names><![CDATA[JMH]]></given-names>
</name>
<name>
<surname><![CDATA[Bejarano]]></surname>
<given-names><![CDATA[SJC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relación entre tiroiditis autoinmune y lupus eritematoso sistémico]]></article-title>
<source><![CDATA[Rev Cuba Reumatol]]></source>
<year>2020</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Graña]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Goñi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Danza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esclerosis sistémica: forma de presentación y manejo terapéutico. Experiencia de un grupo de trabajo en Enfermedades Autoinmunes Sistémicas]]></article-title>
<source><![CDATA[Rev Urug Med Interna]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mussano]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Onetti]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cadile]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Werner]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ruffin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Buliubasich]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lupus eritematoso sistémico: datos sociodemográficos y su correlación clínico-analítica en un hospital universitario]]></article-title>
<source><![CDATA[Rev Argent Reumatol]]></source>
<year>2019</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>5-12</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flores Aguilar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Roque Quezada]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Flores Aguilar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Roque Quezada]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lupus Eritematoso Sistémico Infantil: características neuropsiquiátricas y factores pronóstico en su transición a la adultez]]></article-title>
<source><![CDATA[Andes Pediatr]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Papagoras]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fragoulis]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Zioga]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Simopoulou]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Deftereou]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kalavri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Better outcomes of COVID-19 in vaccinated com- pared to unvaccinated patients with systemic rheumatic diseases]]></article-title>
<source><![CDATA[Ann Rheum Dis]]></source>
<year>2021</year>
<page-range>221-539</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Lawson-Tovey]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Strangfeld]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mateus]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Hyrich]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Gossec]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry]]></article-title>
<source><![CDATA[Ann Rheum Dis]]></source>
<year>2022</year>
<volume>81</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>695-709</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Higgins]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Fabros]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kulasingam]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quantitative measurement of Anti-SARS-CoV-2 Antibodies: Analytical and clinical evaluation]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>2021</year>
<volume>59</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1098-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jena]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bharath]]></surname>
<given-names><![CDATA[PN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Dig Liver Dis]]></source>
<year>2022</year>
<volume>S1590-8658</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>00210-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taborda]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Salcedo]]></surname>
<given-names><![CDATA[DCD]]></given-names>
</name>
<name>
<surname><![CDATA[Guadarrama]]></surname>
<given-names><![CDATA[JDS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos adversos post-aplicación de vacunas COVID 19 en estudiantes del área de la salud de la costa atlántica colombiana]]></article-title>
<source><![CDATA[Dilemas Contemp Educ Política Valores]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cosentino]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Larroude]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Schneeberger]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infectología (SADI) G de expertos de la SA de, Nacinovich F. Consenso de recomen- daciones de vacunas en adultos con enfermedades reumáticas inflamatorias crónicas autoinmunes]]></article-title>
<source><![CDATA[Rev Argent Reumatol]]></source>
<year>2022</year>
<volume>33</volume>
<numero>1Sup</numero>
<issue>1Sup</issue>
<page-range>1-24</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cairoli]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedades autoinmunes y vacunas contra la COVID-19. Toma de decisiones en escenarios de incertidumbre]]></article-title>
<source><![CDATA[Med Clínica]]></source>
<year>2021</year>
<volume>157</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>247-52</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="">
<collab>FDA Briefing Document</collab>
<source><![CDATA[Vaccines and Related Biological Products Advisory Committee Meeting]]></source>
<year>2020</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
